Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(6)
Body Image
Drug Use
Health Risk
Substance Use
Substance Use Disorder
Anabolic Androgenic Steroid
Subscribe
Academic
Publications
The diagnostic dilemma of pathological appearance and performance enhancing drug use
The diagnostic dilemma of pathological appearance and performance enhancing drug use,10.1016/j.drugalcdep.2010.09.018,Fuel and Energy Abstracts,Tom Hi
Edit
The diagnostic dilemma of pathological appearance and performance enhancing drug use
(
Citations: 1
)
BibTex
|
RIS
|
RefWorks
Download
Tom Hildebrandt
,
Justine K. Lai
,
James W. Langenbucher
,
Melanie Schneider
,
Rachel Yehuda
,
Donald W. Pfaff
Appearance and performance enhancing drug (APED) use includes the use of a range of pharmacologically distinct substances and concurrent investment in outward appearance or achievement, dietary control, and frequent exercise. A number of existing reviews and conceptual papers have defined pathological forms of APED use within the APED class of anabolic-androgenic steroids (AASs) and using the framework of AAS dependence. We review published data on APED use including human studies of AAS users and identified three defining phenomenological features associated with increased
health risk
and pathology. These features included (1) polypharmacy or the concurrent use of several pharmacologically distinct substances used to change outward appearance or increase likelihood of personal achievement; (2) significant
body image
disturbance; (3) rigid practices and preoccupations with diet and exercise. Investigations into the latent structure of APED use suggest these features cluster together in a homogenous group of APED users who have the highest
health risk
and most psychopathology. These features are discussed in the context of AAS dependence and problems with defining classic tolerance-withdrawal symptoms among APED users. Suggestions for a resolution and outline for future research needed to determine the best system for identifying and diagnosing pathological APED use are discussed.
Journal:
Fuel and Energy Abstracts
, vol. 114, no. 1, pp. 1-11, 2011
DOI:
10.1016/j.drugalcdep.2010.09.018
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.sciencedirect.com
)
Sort by:
Citations
(1)
Developing a validated liquid chromatography–mass spectrometric method for the simultaneous analysis of five bioactive quassinoid markers for the standardization of manufactured batches of Eurycoma longifolia Jack extract as antimalarial medicaments
Chin-Hoe Teh
,
Vikneswaran Murugaiyah
,
Kit-Lam Chan
Journal:
Journal of Chromatography A - J CHROMATOGR A
, vol. 1218, no. 14, pp. 1861-1877, 2011